Most Recent
Silk on cutting-edge IP cases elevated to Federal Court
A top intellectual property barrister who has worked on cutting-edge cases that raise novel questions about the patentability of inventions has been appointed to the Federal Court.
Peloton’s US$420M acquisition of Precor violated ‘spinning’ licence, court told
California-based fitness company Mad Dogg has accused Peloton Interactive of inducing breach of a non-compete through its $US420 million acquisition of commercial gym equipment manufacturer Precor, and has asked a court to block the company from using its 'spinning' trade marks in relation to its interactive exercise bikes.
Sizzler, Burger Urge lay down steak knives in trade mark battle
Buffet dining pioneer Sizzler, which closed its last Australian restaurants in November, has settled a trade mark dispute with Brisbane-based chain Burger Urge over a chicken burger known as "the Sizzle".
Full Court hears government’s $325M fight with Sanofi over ban on Plavix generic
Pharmaceutical companies Sanofi and Bristol-Myers Squibb are liable for losses to the federal government for excess subsidies it allegedly paid for the blood-thinner Plavix after an unjustified court injunction prevented the release of a generic version of the top-selling drug, an appeals court has heard.
Judge puts sandwiches back on the menu in Sizzler trade mark spat
A judge has ordered buffet restaurant pioneer Sizzler to amend its pleadings in a trade mark stoush with Brisbane-based restaurant Burger Urge to bring them in line with a summary judgment application that includes sandwiches among the classes of allegedly infringed goods.
‘Sydney’s most controversial burger restaurant’ loses appeal in trade mark beef with In-N-Out
The Full Federal Court has upheld an appeal by In-N-Out Burgers against Sydney-based Hashtag Burgers, finding that its two sole directors were also liable for trademark infringement and passing off in owning and operating their 'DOWN-N-OUT' burger restaurants.
Judge allows Neurim to seek additional damages in patent suit over insomnia drug
Neurim Pharmaceuticals can seek limited additional damages in a patent infringement case relating to its insomnia drug Circadin, after a judge granted a mid-trial bid to amend its pleadings against Generic Partners and Apotex.
Mylan fails in High Court bid to save patents for top seller Lipidil
The High Court has declined to take up Mylan's challenge to a Full Court ruling upholding the invalidity of three patents for its blockbuster cholesterol drug Lipidil.
High Court won’t hear Rokt appeal on software patentability
The High Court has declined to weigh in on the patentability of software, rejecting e-commerce company Rokt's bid for review of a decision striking down its marketing invention.
Merck Sharp & Dohme settles trade mark spat with German drug company
US drug company Merck Sharp & Dohme has settled trade mark litigation brought by German drug maker Merck KGaA alleging it violated a 1970 agreement by using the "Merck" mark in Australia.